- Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
-
Yun SJ, Jeong IK, Cha JH, Lee J, Cho HC, Choi SH, Chun S, Jeon HJ, Kang HC, Kim SS, Ko SH, Koh G, Kwon SK, Lee JH, Moon MK, Noh J, Park CY, Kim S
- KMID: 2530185
- Diabetes Metab J.
- 2022 May;46(3):464-475.
- doi: 10.4093/dmj.2021.0088
Background: We evaluated the achievement of low-density lipoprotein cholesterol (LDL-C) targets in patients with type 2 diabetes mellitus (T2DM) according to up-to-date Korean Diabetes Association (KDA), European Society of Cardiology... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid Variability and Diabetes Mellitus
-
Lee J, Lee SH
- KMID: 2528408
- J Korean Diabetes.
- 2022 Mar;23(1):28-34.
- doi: 10.4093/jkd.2022.23.1.28
Diabetic dyslipidemia is characterized by hypertriglyceridemia, low HDL (high-density lipoprotein)-cholesterol, elevated LDL (low-density lipoprotein)-cholesterol, and predominance of small dense LDL particles caused by insulin resistance in type 2 diabetes or... -
- CITED
-
- Close
- SHARE
-
- Close
- Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction
-
Park J, Kang M, Ahn J, Kim MY, Choi MS, Lee YB, Kim G, Hur KY, Kim JH, Yang JH, Jin SM
- KMID: 2527721
- Diabetes Metab J.
- 2022 Mar;46(2):286-296.
- doi: 10.4093/dmj.2021.0080
Background: Subclinical left ventricular diastolic dysfunction (LVDD) is an emerging consequence of increased insulin resistance, and dyslipidemia is one of the few correctable risk factors of LVDD. This study evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Individualized Treatment for Patients With Familial Hypercholesterolemia
-
Tada H, Takamura M, Kawashiri Ma
- KMID: 2525236
- J Lipid Atheroscler.
- 2022 Jan;11(1):39-54.
- doi: 10.12997/jla.2022.11.1.39
Familial hypercholesterolemia (FH) is one of the most common and, therefore, important inherited disorders in preventive cardiology. This disease is mainly caused by a single pathogenic mutation in the low-density... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-achievement of the Low-Density Lipoprotein Cholesterol Goal in Older Patients with Type 2 Diabetes Mellitus and a Very High Cardiovascular Disease Risk: A Multicenter Study in Vietnam
-
Nguyen HT, Ha KPT, Nguyen AH, Nguyen TT, Lam HM
- KMID: 2523708
- Ann Geriatr Med Res.
- 2021 Dec;25(4):278-285.
- doi: 10.4235/agmr.21.0099
Background: Lowering the low-density lipoprotein cholesterol (LDL-c) level is important for reducing cardiovascular (CV) events. However, little is known about the management of LDL-c in older patients with type 2... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of nutrition education and traditional game-based physical activity interventions, on lipid profile improvement in overweight and obese children in West Java Indonesia
-
Yulia C, Khomsan A, Sukandar D, Riyadi H
- KMID: 2518759
- Nutr Res Pract.
- 2021 Aug;15(4):479-491.
- doi: 10.4162/nrp.2021.15.4.479
BACKGROUND/OBJECTIVES: One ongoing effort to curtail dyslipidemia in school children is through lifestyle intervention. This study analyzes outcomes of the intervention of nutrition education and Javanese traditional game-based physical activity,... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation between Serum Lipid Parameters and Interleukin-10 Concentration in Obese Individuals
-
Kim SJ, Lim J, Nam GE, Park HS
- KMID: 2517322
- J Obes Metab Syndr.
- 2021 Jun;30(2):173-177.
- doi: 10.7570/jomes20122
Background: The role of interleukin-10 (IL-10) in humans is controversial because IL-10 has been proposed to exhibit both pro- and anti-inflammatory effects. We aimed to determine the relationships between the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Evolocumab in Patients with Hypercholesterolemia
-
Jin X, Kim MH, Cho YR, Park JS, Song K, Yuan SL
- KMID: 2510273
- Kosin Med J.
- 2020 Dec;35(2):125-132.
- doi: 10.7180/kmj.2020.35.2.125
Objectives: The FOURIER trial reported that inhibition of PCSK9 with evolocumab on a background of statin therapy lowered low-density lipoprotein (LDL) cholesterol levels to a median of 30 mg per... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Dietary Carbohydrate Intake and Cardiovascular Risk Factors According to Low-Density Lipoprotein Cholesterol Levels in Korean Adults
-
Song S, Lee YJ, Song Y
- KMID: 2509875
- Korean J Health Promot.
- 2020 Dec;20(4):182-193.
- doi: 10.15384/kjhp.2020.20.4.182
Background: Low-density lipoprotein (LDL) cholesterol is a strong predictor of cardiovascular disease, resulting in the promotion of low-fat diets that emphasize the need to lower LDL cholesterol levels. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
-
Jeong IK, Kim SR
- KMID: 2511015
- Endocrinol Metab.
- 2020 Dec;35(4):882-891.
- doi: 10.3803/EnM.2020.723
Background: While randomized controlled trials provide useful information about drug safety and efficacy, they do not always reflect the observed results in the real world. The prospective, observational, non-comparative trial... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of Serum Low-Density Lipoprotein Cholesterol Level in Postmenopausal Women
-
Jung D, Choi HJ, Shim YN, Jo MS, Oh HJ
- KMID: 2507720
- Korean J Fam Pract.
- 2020 Oct;10(5):393-397.
- doi: 10.21215/kjfp.2020.10.5.393
Background: In general, women tend to increase serum low-density lipoprotein cholesterol levels after menopause. Hypercholesterolemia is a risk factor that causes atherosclerosis and increases the risk of cardiovascular disease. Additionally,... -
- CITED
-
- Close
- SHARE
-
- Close
- Proprotein convertase subtilisin/kexin type 9 inhibition in cardiovascular disease: current status and future perspectives
-
Cho KH, Hong YJ
- KMID: 2505578
- Korean J Intern Med.
- 2020 Sep;35(5):1045-1058.
- doi: 10.3904/kjim.2020.140
Proprotein convertase subtilisin/kexin type 9 (PCSK 9) targets the degradation of low-density lipoprotein (LDL) receptors; it has been proved that its inhibition improves cardiovascular outcomes in patients with established atherosclerotic... -
- CITED
-
- Close
- SHARE
-
- Close
- Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
-
Yang YS, Lee SY, Kim JS, Choi KM, Lee KW, Lee SC, Cho JR, Oh SJ, Kim JH, Choi SH
- KMID: 2503267
- Endocrinol Metab.
- 2020 Jun;35(2):367-376.
- doi: 10.3803/EnM.2020.35.2.367
Background: This study assessed the proportion of risk-stratified Korean patients with dyslipidemia achieving their low-density lipoprotein cholesterol (LDL-C) targets as defined by the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia
-
Ferro Y, Mazza E, Salvati M, Santariga E, Giampà S, Spagnuolo R, Doldo P, Pujia R, Coppola A, Gazzaruso C, Pujia A, Montalcini T
- KMID: 2503260
- Endocrinol Metab.
- 2020 Jun;35(2):298-307.
- doi: 10.3803/EnM.2020.35.2.298
Background: A growing number of functional foods have been proposed to reduce cholesterol levels and the Portfolio Diet, which includes a combination of plant sterols, fibres, nuts, and soy protein,... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin
-
Kim H, Lee CJ, Choi D, Kim BK, Kim IC, Kim JS, Ahn CM, Hong GR, Cho IJ, Shim CY, Lee SH
- KMID: 2501307
- J Lipid Atheroscler.
- 2020 May;9(2):283-290.
- doi: 10.12997/jla.2020.9.2.283
Objective: The aim of this study was to investigate whether a new generic rosuvastatin is non-inferior to a proprietary one in terms of lipid-lowering efficacy. We also evaluated its non-lipid... -
- CITED
-
- Close
- SHARE
-
- Close
- The Association between Non-Alcoholic Fatty Liver Disease Fibrosis Score and Serum Low Density Lipoprotein-Cholesterol Levels in Adults with Non-Alcoholic Fatty Liver Disease
-
Park SB, Choi HJ, Doo SH, Jung D, Shim YN, Oh HJ
- KMID: 2502318
- Korean J Fam Pract.
- 2020 Apr;10(2):110-115.
- doi: 10.21215/kjfp.2020.10.2.110
Background: Non-alcoholic fatty liver disease fibrosis score (NFS) is a scoring system applied in clinical practice to predict advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Evidence shows... -
- CITED
-
- Close
- SHARE
-
- Close
- The association between mercury concentrations and lipid profiles in the Korean National Environmental Health Survey (KoNEHS) cycle 3
-
Sohn SH, Heo HC, Jo S, Park C, Sakong J
- KMID: 2506296
- Ann Occup Environ Med.
- 2020 ;32(1):e19.
- doi: 10.35371/aoem.2020.32.e19
Background: High concentrations of mercury intake from seafood are known to cause various side effects in humans, including on the nervous system. Various studies have reported the effects of mercury... -
- CITED
-
- Close
- SHARE
-
- Close
- Validation of the Friedewald formula for estimating low density lipoprotein cholesterol: the Korea National Health and Nutrition Examination Survey, 2009 to 2011
-
Lee J, Jang S, Jeong H, Ryu OH
- KMID: 2501996
- Korean J Intern Med.
- 2020 Jan;35(1):150-159.
- doi: 10.3904/kjim.2017.233
Background/Aims: The aim of this study is to compare Friedewald-estimated and directly measured low density lipoprotein cholesterol (LDL-C) values and assess the concordance in guideline risk classification between the two... -
- CITED
-
- Close
- SHARE
-
- Close
- Scavenger Receptor Class A to E Involved in Various Cancers
-
Ryu S, Howland A, Song B, Youn C, Song PI
- KMID: 2468139
- Chonnam Med J.
- 2020 Jan;56(1):1-5.
- doi: 10.4068/cmj.2020.56.1.1
Scavenger receptors typically bind to multiple ligands on a cell surface, including endogenous and modified host-derived molecules and microbial pathogens. They promote the elimination of degraded or harmful substances such... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
-
Nam CW, Kim DS, Li J, Baccara-Dinet MT, Li I, Kim JH, Kim CJ
- KMID: 2463483
- Korean J Intern Med.
- 2019 Nov;34(6):1252-1262.
- doi: 10.3904/kjim.2018.133
BACKGROUND/AIMS: Efficacy and safety data of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), is not yet well established in the Korean population. We assessed... -
- CITED
-
- Close
- SHARE
-
- Close
